Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Morepen Laboratories Ltd. Share Price
Day's Range
Day's Range
Low
₹51.60
High
₹54.20
Price Summary
| Previous Close | ₹53.16 |
|---|---|
| Day's Range | ₹51.60 - ₹54.20 |
| Open | ₹52.37 |
| 52 Week Range | ₹33.05 - ₹66.40 |
| Volume | 1,49,25,806 |
| Market Cap | ₹0.00 |
| Previous Close | ₹53.14 |
|---|---|
| Day's Range | ₹51.58 - ₹54.20 |
| Open | ₹52.20 |
| 52 Week Range | ₹33.44 - ₹66.36 |
| Volume | 7,48,285 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 7,934.56 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.38 |
| Price/Earning (TTM) | 30.07 |
| TTM EPS (₹) | 1.73 |
| P/E Ratio | 22.21 |
| Book Value(₹) | 2.29 |
| PAT Margin (%) | 6.51 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 15.48 |
| Trade Value ( ₹ in Lacs) | 397.64 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.38 |
| Price/Earning (TTM) | 30.07 |
| TTM EPS (₹) | 1.73 |
| P/E Ratio | 22.21 |
| Book Value(₹) | 2.29 |
| PAT Margin (%) | 6.51 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 15.48 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3819.38 | 15545.35 |
| Expenses | N/A | N/A |
| PBT | 173.04 | 1375.86 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 119.11 | 1015.75 |
About Morepen Laboratories Ltd.
| Founded | 1984 |
|---|---|
| Managing Director | Sushil Suri |
| NSE Symbol | MOREPENLAB |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,803.33 | 1,861.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,219.17 | 6,705.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,417.21 | 4,524.00 | 3,165.00 - 3,165.00 |
| Apollo Hospitals Enterprise Ltd. | 1,23,273.78 | 8,589.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,115.65 | 1,439.95 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,10,874.16 | 1,351.00 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,09,635.65 | 1,100.70 | 835.50 - 835.50 |
| Lupin Ltd. | 1,08,263.52 | 2,346.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,05,217.39 | 1,122.85 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,02,255.74 | 2,462.80 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Morepen Laboratories informs about newspaper publication
Morepen Laboratories informs about press release
Morepen Laboratories informs about investor presentation
Mercury Laboratories informs about closure of trading window
Mercury Laboratories has informed that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and as per Company’s Code of Conduct for regulating, monitoring, reporting of trading by insiders, trading window for dealing in securities of the Company by the Designated Persons and their relatives shall remain closed with effect from Wednesday, July 01, 2026. The trading window shall remain closed till 48 hours after the announcement of the unaudited financial results of the Company for the quarter ended on June 30, 2026. The date of the Board Meeting for considering the unaudited financial results for the quarter ended on June 30, 2026 will be intimated in due course
The above information is a part of company’s filings submitted to BSE.
Granules India informs about closure of trading window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Granules Code of Conduct for Prevention of Insider Trading, Granules India has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all Insiders including the Designated Persons and their immediate relatives from July 01, 2026 till 48 hours after the declaration of the un-audited financial results for the first quarter of FY 27 ending on June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Morepen Laboratories Ltd. is ₹53.16 as of 2026-06-25.
The market capitalisation of Morepen Laboratories Ltd. is ₹2,852.65 as of 2026-06-24.
The 1-year return of Morepen Laboratories Ltd. is 1.04% as of 2026-06-25.
The P/E ratio of Morepen Laboratories Ltd. is 22.21 as of 2026-06-25.
The 52-week high and low of Morepen Laboratories Ltd. are ₹66.40 and ₹33.05, respectively, as of 2026-06-25.
People Also Ask
Morepen Laboratories Ltd. offers a broad healthcare portfolio that includes Active Pharmaceutical Ingredients (APIs) such as antihistamines and statins, as well as known branded OTC products like Burnol. Their offerings also extend to a diagnostics division that provides home-health devices, including digital glucose monitors and blood pressure monitors.
Morepen Laboratories Ltd. collaborates with pharmaceutical companies through the supply of Active Pharmaceutical Ingredients (APIs) and contract manufacturing services. The company also supplies diagnostic medical devices and point-of-care testing solutions that are used by hospitals, clinics and other healthcare providers for patient monitoring and diagnostic purposes.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
